Arthur Cox advised LED Group on the deal, and Gibson Dunn & Crutcher advised funds managed by the Power Opportunities strategy of Oaktree Capital Management, L.P....
You must be a Standard 1 Year member to access this content.
Arthur Cox advised UFP Technologies, Inc. on the deal. UFP Technologies, Inc. secured the acquisition of AQF Medical. UFP Technologies is a designer and custom...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Dean Hotel Group on the deal. Dean Hotel Group completed the landmark sale of its eight hotels on the island of Ireland including The...
You must be a Standard 1 Year member to access this content.
Arthur Cox represented Chanelle Pharma on the transaction. Exponent completed the acquisition of Chanelle Pharma, Ireland’s largest indigenous generic pharmaceutical manufacturer of both medical and veterinary products....
You must be a Standard 1 Year member to access this content.
Arthur Cox and Ropes & Gray LLP advised Cambrex Corporation. Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised UFP Technologies, Inc. (Nasdaq: UFPT) on the deal. UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products,...
You must be a Standard 1 Year member to access this content.
